Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
862 RESULTS FOUND
2018 AdvaMed Accel Board Meeting Schedule
June 8, 2017 | Agenda
Weekly AdvaMed Accel Policy Update (T&R) - June 6, 2017
June 6, 2017 | Agenda
AdvaMed Comments on Health Canada Public Release of Clinical Information
May 25, 2017 | Comments
AdvaMed Comments on Docket No. FDA-2017-D-0040; Draft Guidance for Industry: How to Prepare a Pre- Request for Designation (Pre-RFD)
May 24, 2017 | Comments
AdvaMed Comments on Docket Number FDA-2017-N-0041 Agency Info Collection Activities
May 15, 2017 | Comments
AdvaMed Comments on FDA-2017-N-1129 Class II Exemptions
May 15, 2017 | Comments
Understanding Evidence about the Value of Medical Technologies
May 12, 2017 | Summary
Use Case: Application of the Medtech Value Assessment Framework to Rotation Medical’s Bioinductive Implant
May 11, 2017 | White Paper
A Framework for Comprehensive Assessment of the Value of Diagnostic Tests
May 11, 2017 | White Paper
A Framework for Comprehensive Assessment of Medical Technologies
May 11, 2017 | White Paper
Short Paper: A Framework for Comprehensive Assessment of Medical Technologies
May 11, 2017 | White Paper
Use Case: Application of the Comprehensive Assessment of the Value of Diagnostic Technologies Framework to Abbott’s Vysis ALK Break Apart FISH Probe Kit Test
May 11, 2017 | White Paper
Use Case: Application of the Comprehensive Assessment of the Value of Diagnostic Technologies Framework to Exact Sciences Cologuard Multi-target sDNA Test
May 11, 2017 | White Paper
Use Case: Application of the Comprehensive Assessment of the Value of Diagnostic Technologies Framework to Abbott’s 4th Generation ARCHITECT HIV Antigen/Antibody Combo Test
May 11, 2017 | White Paper
Use Case: Application of the Medtech Value Assessment Framework to Cymedica’s e-vive™ System
May 11, 2017 | White Paper
Use Case: Application of the Medtech Value Assessment Framework to Siemens Coronary Computed Tomography Angiography (CCTA)
May 11, 2017 | White Paper
Position: Director, State Government & Regional Affairs
May 4, 2017 | Administrative
Medtech and a Vibrant Japan – A report by The Economist Intelligence Unit (EIU) – April 2017 (English)
April 27, 2017 | Administrative
Medtech and a Vibrant Japan – A report by The Economist Intelligence Unit (EIU) – April 2017 (Japanese)
April 27, 2017 | Administrative
Medical-Device Makers’ Representatives in the O.R.: Patient-Care Benefits and Legal Ramifications
April 21, 2017 | White Paper
Advamed Comments on Docket Number FDA-2016-D-2285 Consistent Communications
April 19, 2017 | Comments
AdvaMed Comments on FDA-2016-N-1149 Unapproved Use Communications
April 19, 2017 | Comments
AdvaMed Comments on Docket Number FDA-2016-D-1307 Communications with Payors Formulary Committees & Similar Entities
April 19, 2017 | Comments
AdvaMed Comments on FDA-2016-N-1149 Unapproved Use Communications Attachment A
April 19, 2017 | Comments
AdvaMed Comments on FDA-2016-N-1149 Unapproved Use Communications Attachment B
April 19, 2017 | Comments

Pages